This mechanism is the foundation of its documented ability to stimulate keratinocyte, endothelial cell, and stem/progenitor cell migration to sites of tissue damage in pre-clinical models
The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [1,2,3,4,5,6,7,8,9,10,11], is known to have pleiotropic beneficial effects [1,2,3,4,5,6,7,8,9,10,11] and to interact with several molecular pathways [2, 27,28,29,30,31,32]
Structural optimization: Further reduce IGFBP binding ability through site directed mutagenesis, or introduce transmembrane peptides to enhance tissue penetration
It is a complex mechanism
Perhaps
Liposomes are naturally found in colostrum and breast milk, where maximum absorption and utilization are essential